|
| 36702318 | Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy. | Neurobiol Dis | 2023 |
| 37943478 | The relationship between synaptodendritic neuropathology and HIV-associated neurocognitive disorders is moderated by cognitive reserve. | J Neurovirol | 2023 |
| 37812315 | Correction to: The anti-cancer drug Sunitinib promotes autophagy and protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. Journal of NeuroVirology 2017. | J Neurovirol | 2023 |
| 37719154 | Nicotine-mediated effects in neuronal and mouse models of synucleinopathy. | Front Neurosci | 2023 |
| 37690676 | Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's disease. | Neurobiol Dis | 2023 |
| 37461624 | Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies <i>LRRC4C, LHX5-AS1</i> and nominates ancestry-specific loci <i>PTPRK</i> , <i>GRB14</i> , and <i>KIAA0825</i> as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. | medRxiv | 2023 |
| 37460684 | Author Correction: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies. | NPJ Vaccines | 2023 |
| 36702318 | Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy. | Neurobiol Dis | 2023 |
| 37058563 | Characterization of altered molecular mechanisms in Parkinson's disease through cell type-resolved multiomics analyses. | Sci Adv | 2023 |
| 37425910 | Genome-wide association study identifies a new susceptibility locus in <i>PLA2G4C</i> for Multiple System Atrophy. | medRxiv | 2023 |
| 36603548 | Parkinson's Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein. | Neuron | 2023 |
| 37522208 | Hippocampal Reduction of α-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice. | J Alzheimers Dis | 2023 |
| 37163617 | Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD. | Sci Transl Med | 2023 |
| 36915530 | A novel splicing variant of DJ-1 in Parkinson's disease induces mitochondrial dysfunction. | Heliyon | 2023 |
| 36847016 | Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay. | J Parkinsons Dis | 2023 |
| 36785484 | Differential involvement of amyloidogenic evolvability in oligodendropathies; Multiple Sclerosis and Multiple System Atrophy. | Prion | 2023 |
| 37719154 | Nicotine-mediated effects in neuronal and mouse models of synucleinopathy. | Front Neurosci | 2023 |
| 37522208 | Hippocampal Reduction of α-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice. | J Alzheimers Dis | 2023 |
| 37943478 | The relationship between synaptodendritic neuropathology and HIV-associated neurocognitive disorders is moderated by cognitive reserve. | J Neurovirol | 2023 |
| 37690676 | Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's disease. | Neurobiol Dis | 2023 |
| 37812315 | Correction to: The anti-cancer drug Sunitinib promotes autophagy and protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. Journal of NeuroVirology 2017. | J Neurovirol | 2023 |
| 37460684 | Author Correction: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies. | NPJ Vaccines | 2023 |
| 37425910 | Genome-wide association study identifies a new susceptibility locus in <i>PLA2G4C</i> for Multiple System Atrophy. | medRxiv | 2023 |
| 37058563 | Characterization of altered molecular mechanisms in Parkinson's disease through cell type-resolved multiomics analyses. | Sci Adv | 2023 |
| 37163617 | Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD. | Sci Transl Med | 2023 |
| 37461624 | Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies <i>LRRC4C, LHX5-AS1</i> and nominates ancestry-specific loci <i>PTPRK</i> , <i>GRB14</i> , and <i>KIAA0825</i> as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. | medRxiv | 2023 |
| 36785484 | Differential involvement of amyloidogenic evolvability in oligodendropathies; Multiple Sclerosis and Multiple System Atrophy. | Prion | 2023 |
| 36915530 | A novel splicing variant of DJ-1 in Parkinson's disease induces mitochondrial dysfunction. | Heliyon | 2023 |
| 36847016 | Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay. | J Parkinsons Dis | 2023 |
| 36603548 | Parkinson's Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein. | Neuron | 2023 |
| 34766306 | Novel Brain-Penetrating Single Chain Antibodies Directed Against 3RTau for the Treatment of Alzheimer's Disease and Related Dementias. | Methods Mol Biol | 2022 |
| 35396576 | Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS. | Exp Mol Med | 2022 |
| 35591950 | Reconsideration of Alzheimer's Disease Therapy from a Viewpoint of Amyloidogenic Evolvability. | J Alzheimers Dis Rep | 2022 |
| 35890306 | Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody. | Pharmaceutics | 2022 |
| 35682759 | Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein. | Int J Mol Sci | 2022 |
| 36333098 | CSF1R-Mediated Myeloid Cell Depletion Prolongs Lifespan But Aggravates Distinct Motor Symptoms in a Model of Multiple System Atrophy. | J Neurosci | 2022 |
| 36064424 | Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits in a mouse model of DLB/PD. | Mol Neurodegener | 2022 |
| 35013319 | Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies. | NPJ Vaccines | 2022 |
| 34766306 | Novel Brain-Penetrating Single Chain Antibodies Directed Against 3RTau for the Treatment of Alzheimer's Disease and Related Dementias. | Methods Mol Biol | 2022 |
| 35396576 | Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS. | Exp Mol Med | 2022 |
| 35591950 | Reconsideration of Alzheimer's Disease Therapy from a Viewpoint of Amyloidogenic Evolvability. | J Alzheimers Dis Rep | 2022 |
| 35682759 | Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein. | Int J Mol Sci | 2022 |
| 36333098 | CSF1R-Mediated Myeloid Cell Depletion Prolongs Lifespan But Aggravates Distinct Motor Symptoms in a Model of Multiple System Atrophy. | J Neurosci | 2022 |
| 36064424 | Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits in a mouse model of DLB/PD. | Mol Neurodegener | 2022 |
| 35890306 | Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody. | Pharmaceutics | 2022 |
| 35013319 | Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies. | NPJ Vaccines | 2022 |
| 32467645 | NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models. | Mol Psychiatry | 2021 |
| 32467645 | NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models. | Mol Psychiatry | 2021 |
| 33639338 | Age-related increase of alpha-synuclein oligomers is associated with motor disturbances in L61 transgenic mice. | Neurobiol Aging | 2021 |
| 33589841 | Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. | Nat Genet | 2021 |